Showing results (251-260 of 288) with videos related to

Sort By:
Pageof 29
Hepatology (Baltimore, Md.)|February 12, 2025
Global burden of HBV-related liver disease: Primary liver cancer due to chronic HBV infection increased in over one-third of countries globally from 2000 to 2021Pojsakorn Danpanichkul, Kwanjit Duangsonk, Vincent L Chen, et al.
Digestive Diseases and Sciences|June 28, 2024
Sex and Race-Ethnic Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease: An Analysis of 40,166 IndividualsClarissa Elysia Fu, Margaret Teng, Daniel Tung, et al.
The American Journal of Medicine|May 2, 2025
Longitudinal Clinical Outcomes and Mortality from Steatotic Liver Disease: A Meta-AnalysisDo Han Kim, Donghyun Ko, Pojsakorn Danpanichkul, et al.
Postgraduate Medical Journal|October 22, 2020
Impact of exposure to patients with COVID-19 on residents and fellows: an international survey of 1420 traineesAnne L Cravero, Nicole J Kim, Lauren D Feld, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 11, 2023
Ethnic disparities in waitlist outcomes of patients with nonalcoholic steatohepatitis listed for liver transplantation in the USWen Hui Lim, Jie Ning Yong, Christen En Ya Ong, et al.
Alimentary Pharmacology & Therapeutics|February 2, 2024
Meta-analysis: Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosisWen Hui Lim, Phoebe Tay, Cheng Han Ng, et al.
Hepatology (Baltimore, Md.)|July 19, 2024
Comparative efficacy of pharmacologic therapies for MASH in reducing liver fat content: Systematic review and network meta-analysisBenjamin Koh, Jieling Xiao, Cheng Han Ng, et al.
Alimentary Pharmacology & Therapeutics|May 29, 2024
Socio-economic association of alcohol use disorder and cardiovascular and alcohol-associated liver disease from 2010 to 2019Pojsakorn Danpanichkul, Vincent L Chen, Nathorn Chaiyakunapruk, et al.
The American Journal of Gastroenterology|January 14, 2026
Imaging Based Modalities for Identifying "At Risk" MASH. A Diagnostic Test Meta-analysisShyna Zhuoying Gunalan, Michelle Shi Ni Law, Yi Xin Kua, et al.
Alimentary Pharmacology & Therapeutics|September 11, 2023
The silent burden of non-alcoholic fatty liver disease in the elderly: A global burden of disease analysisPojsakorn Danpanichkul, Cheng Han Ng, Mark D Muthiah, et al.
Pageof 29